Navigation Links
EvaluatePharma Japan KK - Now Open for Business in Tokyo
Date:9/15/2011

LONDON and TOKYO, September 15, 2011 /PRNewswire/ --

EvaluatePharma Ltd, the research company, is delighted to announce the official launch of EvaluatePharma Japan KK.  With a team based in Tokyo, EvaluatePharma Japan KK will be ideally placed to support our clients and prospects in Japan.

"Japan is a very important market for us.  We have managed to build close relationships with our major customers from a distance, but it is now time for us to show our commitment to the Japanese market with a dedicated local operation," said CEO Dr Jonathan de Pass.

With the establishment of EvaluatePharma Japan KK, we welcome Hiroshi Yamazaki, who has joined as a regional director. Mr. Yamazaki is responsible for development of EvaluatePharma's business in Japan.  With many years' experience servicing the pharmaceutical industry, he and the EvaluatePharma Japan team are well positioned to expand and support the business in this territory.

The launch was marked with a reception at the British Embassy in Tokyo, where Dr Jonathan de Pass, founder and CEO of EvaluatePharma Ltd, presented "Darwin's Medicine - Survival of the Fittest in the Pharma Industry."  Drawing on EvaluatePharma's World Preview 2016 (2011 edition), and "The Future of Pharma" by Professor Brian D. Smith, Dr de Pass discussed the evolutionary forces shaping the pharmaceuticals industry in the face of catastrophic loss of revenue post "patent cliff" and the alarming decline in R&D productivity.

Notes to editors

About EvaluatePharma ® - http://www.evaluatepharma.com

Set up in 1996 by former top pharma analyst Dr. Jonathan de Pass, EvaluatePharma® is the premier source for pharma and biotech analysis.

EvaluatePharma was the first company to supply reliable consensus forecasts of global drug sales and now provides standardised worldwide financial and for
'/>"/>

SOURCE EvaluatePharma Ltd
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. EYLEAâ„¢ (aflibercept injection) Submitted in Japan for Marketing Authorization for the Treatment of Wet Age-Related Macular Degeneration
2. Reverse NanoJapan: Rice to host 25-30 Japanese students
3. Cellectis bioresearch Appoints Wako as Exclusive Distributor of its Genome Customization Solutions in Japan
4. Epichem and AR Brown Sign Exclusive Distribution Agreement for Japan, Taiwan, China and South Korea
5. Silence Therapeutics Issued Japanese Patent Covering its Core RNA Interference (RNAi) Technology
6. The Center for Business Intelligence Donates to the American Red Cross, Matching Employee Contributions for Disaster Relief in Japan
7. 50,000 Potassium Iodide Pills Donated to Japan
8. UBM Announces Content for 10th Annual Japanese Pharma & Bio Events
9. Reportlinker Adds The 2011 Clinical Chemistry and Immunodiagnostics Markets: US, Europe, Japan; Product Development Opportunities and Business Expansion Strategies for Instrument and Reagent Suppliers
10. Reportlinker Adds The 2011 Blood Banking Market: US, Europe, Japan - Emerging Opportunities and Business Expansion Strategies for Suppliers
11. Reportlinker Adds The 2011 Immunoprotein Diagnostics Market: US, Europe, Japan Test Volume and Sales Forecasts by Country and Market Segment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/16/2015)... , April 16, 2015  In recognition of World ... with hemophilia advocacy groups to illuminate more than 15 prominent ... including Boston,s Zakim Bridge and Prudential ... New Orleans, Mercedes-Benz Superdome and Denver,s ... during the evening of April 17, and coincide with hemophilia ...
(Date:4/16/2015)... , April 16, 2015 /CNW/ - Bioenterprise Corporation is ... newest office in Charlottetown , PEI.  ... Prince Edward Island ADAPT Council for the commercialization of ... forward to working with PEI ADAPT.  They have been ... more than a decade," explains Dave Smardon , ...
(Date:4/16/2015)... 16, 2015  AnaptysBio, Inc., a leader in ... today announced the advancement of its first-in-class ... studies. The Company,s anti-IL-36R therapeutic antibody, called ... pustular psoriasis (GPP), an orphan systemic inflammatory ... wholly owned within AnaptysBio,s proprietary antibody pipeline ...
(Date:4/16/2015)... , April 16, 2015  EMD Serono ... KGaA, Darmstadt, Germany , appointed ... President, Head of Global Clinical Development.  Dr. Reicin ... including experience in Oncology and Immunology. She is ... having served as a Vice President in various ...
Breaking Biology Technology:Biogen Shines A Light On Hemophilia Community By Illuminating U.S. Landmarks Red On World Hemophlia Day 2Biogen Shines A Light On Hemophilia Community By Illuminating U.S. Landmarks Red On World Hemophlia Day 3Biogen Shines A Light On Hemophilia Community By Illuminating U.S. Landmarks Red On World Hemophlia Day 4Bioenterprise Corporation Expands into the Maritimes 2AnaptysBio Advances First-In-Class Anti-IL-36 Receptor Antibody Program To Treat Orphan Inflammatory Disease 2Alise Reicin Joins the Biopharmaceutical Business of Merck KGaA, Darmstadt, Germany as Head of Global Clinical Development 2Alise Reicin Joins the Biopharmaceutical Business of Merck KGaA, Darmstadt, Germany as Head of Global Clinical Development 3
... , ARMSTRONG, Iowa, Nov. 16 Art,s Way ... subsidiary, Art,s Way Scientific, Inc. - Buildings For Science - ... farrowing, nursery and finisher operations. The complex will be used ... swine production. Research projects will include trials on nutrition, physiology ...
... Nov. 16 Hollis-Eden Pharmaceuticals, Inc. (Nasdaq: HEPH ... I/II clinical trial with Apoptone® (HE3235) for hormone-resistant prostate ... Presented at the Molecular Targets and Cancer Therapeutics ... EORTC, the poster is titled: "Results of ...
... , SEATTLE, Nov. 16 /PRNewswire-FirstCall/ - Oncothyreon ... that the Company,s product candidate PX-866, a PI-3 kinase ... one of the Top 10 most promising oncology projects ... selection was made by an independent committee assembled by ...
Cached Biology Technology:Art's Way Manufacturing Announces Contract for Modular Swine Facility for the University of Georgia 2Art's Way Manufacturing Announces Contract for Modular Swine Facility for the University of Georgia 3Hollis-Eden Presents New Interim Data From Prostate Cancer Phase I/II Clinical Studies of Apoptone (HE3235) at AACR Molecular Targets and Cancer Therapeutics Conference 2Hollis-Eden Presents New Interim Data From Prostate Cancer Phase I/II Clinical Studies of Apoptone (HE3235) at AACR Molecular Targets and Cancer Therapeutics Conference 3Hollis-Eden Presents New Interim Data From Prostate Cancer Phase I/II Clinical Studies of Apoptone (HE3235) at AACR Molecular Targets and Cancer Therapeutics Conference 4Oncothyreon's PX-866 PI-3 kinase inhibitor named among Top 10 most promising oncology products for partnering by Windhover 2Oncothyreon's PX-866 PI-3 kinase inhibitor named among Top 10 most promising oncology products for partnering by Windhover 3
(Date:3/23/2015)... LOS ANGELES , March 23, 2015  In ... in Federal fraud case conviction losses. This figure accounts ... fraud, which, according to The Nilson Report, exceeds $11 ... an investigative tool after a crime has occurred. Investor ... Agent and polygraph expert Joe Paolella partnered ...
(Date:3/20/2015)... Mar. 20, 2015 Research and Markets ... of the "India Sensors Market Forecast and ... The sensor market is projected to grow ... Consumer electronics, automotive, industrial and healthcare sectors ... the country. In addition, adoption of MEMS technology ...
(Date:3/20/2015)... Conn. , March 20, 2015 NXT-ID, ... a biometric authentication company focused on the growing mobile ... smart wallet is one of the products featured in ... March 20th at 11:00 PM EST on the DIY ... to Las Vegas , site of ...
Breaking Biology News(10 mins):Polygraph Test Now Used to Protect Investors From Fraud 2Polygraph Test Now Used to Protect Investors From Fraud 3India Sensors Market Forecast and Opportunities 2020 - STMicroelectronics held the largest share in 2014 2India Sensors Market Forecast and Opportunities 2020 - STMicroelectronics held the largest share in 2014 3NXT-ID's Wocket Biometric Smart Wallet to Air on "I Want That" International CES Special 2NXT-ID's Wocket Biometric Smart Wallet to Air on "I Want That" International CES Special 3
... high blood pressure drugs may be useful in preventing and ... people with diabetes. The study, the largest to date on ... prevent or treat the sight-threatening disease, they say. The findings ... monthly publication. Edward Feener and colleagues point out ...
... Pneumonia A group led by Dr. James ... Human Infectious Diseases Research of The Methodist Hospital Research ... Paton-Valentine leukocidin (PVL) does not affect methicillin-resistant Staphlococcus ... can be found in the March 2010 issue of ...
... -- Oak Ridge National Laboratory researchers will lead projects ... processor hours of computing time on supercomputers located at ... awards were made through the U.S. Department of Energy ... Experiment (INCITE) program. This year, the INCITE program will ...
Cached Biology News:Tips from the American Journal of Pathology 2Tips from the American Journal of Pathology 3Tips from the American Journal of Pathology 4Tips from the American Journal of Pathology 52010 DOE INCITE projects allocated at ORNL 22010 DOE INCITE projects allocated at ORNL 32010 DOE INCITE projects allocated at ORNL 4
Mouse monoclonal [CAT-2] to Chloramphenicol Acetyltransferase...
... Immunogen corresponds to amino acids 2-105 from ... been successfully used in Western blot, immunocytochemistry ... this antibody detects an ~ 60 kDa ... also been used in immunoprecipitation and immunocytochemical ...
... chromatography, Affi-Prep protein A media yield ... IgG prior to analysis of other ... for antigen purification. Protein A binds ... especially IgG from mammalian species. This ...
Determin interaction of your protein with Echelons lipids...
Biology Products: